Dark Matter launches Developer Portal, opening the Empower LOS to external innovation
JACKSONVILLE, Fla., April 24, 2025 (SEND2PRESS NEWSWIRE) — Dark Matter Technologies (Dark Matter®), an innovative leader in mortgage technology, today unveiled a new Developer Portal during its second annual Horizon user conference.
The Developer Portal marks a significant evolution for the Empower® loan origination system (LOS), moving from API access to a fully open API ecosystem. By providing external developers with self-service access to documentation, code samples and integration guides, the portal removes barriers to innovation and enables clients and partners to build on Empower with greater speed and independence.
'By making our APIs and developer resources more accessible, we're unlocking new possibilities for our clients and partners to solve their unique business challenges, differentiate their offerings and move more quickly from concept to implementation,' said Sean Dugan, CEO of Dark Matter.
Designed with the developer experience in mind, the portal delivers a modern, frictionless interface that helps users get up and running fast. It supports a wide range of development use cases, from integrating customer relationship management systems to building custom workflows, allowing organizations to extend the Empower platform in ways that align with their business strategies.
'While Dark Matter has long offered APIs, this launch represents a major leap forward in how we support developers,' said Vikas Rao, deputy chief product officer at Dark Matter. 'We've intentionally designed this portal to give developers everything they need to be productive, from clean documentation to practical code samples, so that they can build innovative tools on Empower with minimal friction.'
The Developer Portal is available now to all Empower LOS customers at no additional cost. Clients can access the portal by contacting their account manager for support.
Dark Matter's Horizon user conference is an invitation-only event April 23-25 and focused on exploring the 'horizon' of mortgage technology.
About Dark Matter Technologies:
Operating with the nimble nature of a startup and the disciplined maturity of one of the industry's leading providers, Dark Matter Technologies delivers powerful technology with unparalleled automation and relentless innovation to leading mortgage lenders, servicers and companies nationwide. For more information, visit www.dmatter.com.
Tags: @dmattertech #fintech #financialservices #marketing #mortgage
NEWS SOURCE: Dark Matter Technologies
###
MEDIA ONLY CONTACT:
(not for publication online or in print)
Elizabeth Schroeder
Depth for Dark Matter Technologies
209.774.6555
[email protected]
###
Keywords: FinTech, Dark Matter Technologies, fintech mortgage tech, API, Empower LOS, loan origination system, JACKSONVILLE, Fla.
This press release was issued on behalf of the news source (Dark Matter Technologies) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P125714 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/dark-matter-launches-developer-portal-opening-the-empower-los-to-external-innovation/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
proteanTecs Launches Solution for System Production Analytics Based on Chip Telemetry
BUSINESS WIRE)--proteanTecs®, a global leader in deep data solutions for electronics health and performance monitoring, today unveiled a revolutionary solution for system production testing that combines embedded on-chip telemetry with an ML-driven analytics engine, introducing deep data sources and insights that were previously inaccessible under today's current production methods. To learn more, download the white paper here. Bridging the silicon-system gap, this telemetry reveals how the chip behaves within the system context, not just in isolation. Share As system companies integrate increasingly advanced chips onto their boards for high-performance markets such as AI, Cloud, Telecommunications, and Automotive, the complexity of system production continues to rise. Ensuring quality, performance, and lifetime reliability, while minimizing test costs and production time has become a significant challenge. proteanTecs enables first-ever parametric visibility during functional test, enabling real-time insights when software meets silicon. It allows system vendors to detect hidden failures, such as power integrity, thermal, and assembly faults as well as optimize performance, and improve power efficiency, at scale and in real time, bridging the longstanding gap between silicon and system behavior. At the heart of the solution is a hardware-embedded monitoring system that uses on-chip Agents to capture deep data throughout the production lifecycle. It is combined with a cloud-based analytics platform and edge-deployed ML models for inline test decisions from new product introduction (NPI) to high-volume manufacturing (HVM). 'Our embedded HW monitoring system serves as a sophisticated monitor for the system, capturing critical telemetry. Together with a dedicated software stack, system quality, power consumption, and performance are significantly improved,' said Evelyn Landman, proteanTecs co-founder and CTO. 'We deliver the first-ever deep parametric visibility during PCB, Module, and System functional testing – under actual workloads and configurations.' Built to accelerate system bring-up and in-depth characterization, proteanTecs simplifies debug and helps teams identify root causes faster – providing critical feedback to design and production test teams and ensuring better system readiness for volume production. During mass production, the solution provides ongoing, cloud-based monitoring and analytics to improve production efficiency and quality. It supports population-based analysis to track trends, anomalies, and system behavior across large volumes, enhancing quality and reliability. 'Bridging the silicon-system gap, this telemetry reveals how the chip behaves within the system context, not just in isolation,' added Landman. 'It provides a new layer of data – not derived, not inferred, but monitored directly from within the chip.' 'Today's rapid adoption of complex AI, hyperscale computing is stretching traditional system production methods beyond their limits,' said Uzi Baruch, Chief Strategy Officer at proteanTecs. 'We're transforming test from a static, reactive process to a predictive, data-driven workflow that adapts to each device's actual behavior. This empowers teams to move beyond oversimplified worst-case assumptions and into an era of precision performance tuning and quality assurance.' The solution is already deployed by leading system vendors – delivering measurable return on investment, underscoring its value as a critical enabler of modern production excellence. Download the full white paper to learn how proteanTecs offers new levels of visibility for functional testing to improve reliability, efficiency, and performance in high performance electronic systems. Contact Us to schedule a demo. proteanTecs is the leading provider of deep data analytics for advanced electronics monitoring. Trusted by global leaders in the datacenter, automotive, communications and mobile markets, the company provides system health and performance monitoring, from production to the field. By applying machine learning to novel data created by on-chip monitors, the company's deep data analytics solutions deliver unparalleled visibility and actionable insights – leading to new levels of quality and reliability. Founded in 2017 and backed by world-leading investors, the company is headquartered in Israel and has offices in the United States, India and Taiwan.
Business Wire
3 hours ago
- Business Wire
Caesars Entertainment Bolsters Online Casino Live Dealer Offering with the Launch of Branded Live Dealer Studio in Michigan
LAS VEGAS--(BUSINESS WIRE)--Caesars Entertainment, Inc. (NASDAQ: CZR) ('Caesars') today announced the launch of its third branded online casino live dealer studio, available now to players on Caesars Palace Online Casino, Horseshoe Online Casino and Caesars Sportsbook & Casino in Michigan. Developed in partnership with Evolution, the new studio reinforces Caesars' commitment to delivering world-class, immersive experiences across its online platforms, inspired by the iconic atmosphere of its Caesars Rewards ® destinations. The debut of the new studio marks Caesars' third branded live dealer studio that has opened in 2025 and draws inspiration from table game play at the Las Vegas Strip's most iconic casino, Caesars Palace. Its opening follows the successful launch of Caesars' first branded studio with Evolution in Pennsylvania in January. In April, the Company also debuted its first studio inside a Caesars Rewards destination at Tropicana Atlantic City in New Jersey. 'Our third live dealer studio expands our fully customized live dealer experience that is already extremely popular in Pennsylvania and New Jersey into another key jurisdiction where our online casino platforms are live,' said Matthew Sunderland, Senior Vice President and Chief iGaming Officer at Caesars Digital. 'The studio design takes inspiration from our flagship destination, Caesars Palace, to authentically recreate the atmosphere of Las Vegas for online players. We look forward to our Michigan players enjoying the new experience.' The new live dealer studio in The Great Lakes State is composed of five blackjack tables, including a VIP-exclusive blackjack table, one roulette table, and one baccarat table. The tables are adorned with custom-branded felts featuring iconic Caesars destinations and each marquee online casino platform, including Caesars Palace Online Casino, Caesars Sportsbook & Casino, Horseshoe Online Casino, and, for the first time, Tropicana Online Casino. Select tables also feature custom felts co-branded through partnerships with professional sports teams. Like Caesars Rewards destinations across North America, the studio caters to VIP players with an exclusive high-limit blackjack table offering an authentic 1-to-1 live experience that could previously only be found in a physical casino. 'As the global leader in online live casino with nearly two decades of experience, Evolution is proud to partner once again with Caesars to launch this bespoke live dealer studio in Michigan,' said Marcus Huber, Chief Commercial Officer of Evolution North America. 'The studio brings the unmistakable character of Caesars' iconic destinations to the online space, offering players in the state a polished, immersive entertainment experience that mirrors the energy and elegance of the casino floor. It's another bold step forward in our shared commitment to innovation and quality at scale in the online live casino market.' Caesars Palace Online Casino, Horseshoe Online Casino and Caesars Sportsbook & Casino are available on iOS, Android, and desktop for those 21 and older in New Jersey, Pennsylvania, Michigan, Ontario, and West Virginia. Each platform offers a dynamic online casino experience with a range of unique Caesars-branded games alongside hundreds of classic land-based casino favorites and core casino game mechanics, including high limit slots, private live dealer tables, linked progressive jackpots, variations of poker and roulette, and more. Caesars' easy-to-navigate online casino apps and desktop platforms also tie online gaming to the Company's industry-leading customer loyalty program, Caesars Rewards. Players in the United States earn Caesars Rewards Credits through their online and in-person casino play that can be redeemed for unforgettable Caesars Rewards experiences at one of Caesars' more than 50 world-class destinations across North America. Caesars Entertainment is an industry leader in Responsible Gaming, known for pioneering Responsible Gaming awareness and education. In 1989, Caesars became the first commercial casino company to address problem gambling by launching the industry's first Responsible Gaming program, Project 21. Today, the Company's commitment to ensuring all players are aware of Responsible Gaming resources remains steadfast and spans all of Caesars' digital platforms and world-class destinations in which it operates. Caesars Entertainment proudly enforces an enhanced 21+ gaming policy that prevents individuals under the age of 21 from using Caesars Rewards and restricts access to its gaming products for individuals under the age of 21. This includes all Caesars Sportsbook operations in New Jersey. In March 2024, Caesars Sportsbook received the prestigious RG Check accreditation from the Responsible Gambling Council in Ontario, Canada, which recognizes companies that achieve the highest standards for their Responsible Gaming practices. Just a few months later, the Company was awarded the National Council on Problem Gambling's award for Corporate Social Responsibility. For more information about Caesars Entertainment's Responsible Gaming program, please visit *For hi-res photos and video, click here * About Caesars Entertainment, Inc. Caesars Entertainment, Inc. (NASDAQ: CZR) is the largest casino-entertainment Company in the U.S. and one of the world's most diversified casino-entertainment providers. Since its beginning in Reno, NV, in 1937, Caesars Entertainment, Inc. has grown through development of new resorts, expansions and acquisitions. Caesars Entertainment, Inc.'s resorts operate primarily under the Caesars®, Harrah's®, Horseshoe®, and Eldorado® brand names. Caesars Entertainment, Inc. offers diversified gaming, entertainment and hospitality amenities, one-of-a-kind destinations, and a full suite of mobile and online gaming and sports betting experiences. All tied to its industry-leading Caesars Rewards loyalty program, the Company focuses on building value with its guests through a unique combination of impeccable service, operational excellence and technology leadership. Caesars is committed to its employees, suppliers, communities and the environment through its PEOPLE PLANET PLAY framework. Know When To Stop Before You Start.® Gambling Problem? Call or text 1-800-GAMBLER. For more information, please visit About Evolution Evolution AB (publ) ('Evolution') develops, produces, markets and licenses fully-integrated B2B Live Casino solutions to gaming operators. Since its inception in 2006, Evolution has developed into a leading B2B provider with 800+ operators among its customers. The group currently employs over 22,000 people in studios across Europe, North and South America. The parent company is based in Sweden and listed on Nasdaq Stockholm with the ticker EVO. Visit for more information. Evolution is licensed and regulated by the Malta Gaming Authority under license MGA/B2B/187/2010. Evolution is also licensed and regulated in many other jurisdictions, including the United Kingdom, Belgium, Canada, Romania, South Africa. Casino app & website available in MI, NJ, PA, WV and ON only. Must be 21+ and physically present in MI, NJ, PA and WV only. See for full terms. Void where prohibited. Know When To Stop Before You Start®. Gambling Problem? MI, NJ, WV, PA (Affiliated with Harrah's Philadelphia): If you or someone you know has a gambling problem, crisis counseling and referral services can be accessed by calling 1-800-GAMBLER (1-800-426-2537) or WV: Visit ON: Visit or call 1-866-531-2600 or text CONNEX to 247247. Accruing Caesars Rewards credits is currently not available in Ontario when using Caesars Palace Online Casino and Caesars Sportsbook & Casino. ©2025, Caesars Entertainment
Business Wire
3 hours ago
- Business Wire
Scipher and Savant Bio Partner to Build the Most Comprehensive Clinico-Genomic Dataset in Rheumatoid Arthritis
NEW YORK & WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a leader in precision immunology, and Savant Bio, a Roivant-backed health data infrastructure company, today announced an expanded strategic partnership to build the world's most advanced clinicogenomic dataset in rheumatoid arthritis (RA). The collaboration aims to generate high-resolution insights to support academic research, clinical trial design, therapeutic strategy, and real-world evidence generation. The collaboration centers on transforming real-world data from the electronic health records (EHRs) of patients tested with Scipher's clinically validated molecular signature test that predicts non-response to TNF inhibitor therapies, PrismRA ®. These data will be converted into structured, analysis-ready formats. By integrating deep genomic insights with comprehensive clinical context, the partnership aims to generate actionable real-world evidence to accelerate drug development in RA and related autoimmune conditions. 'Enormous potential is locked inside real-world clinical data, but much of it lives in an unstructured form,' said Brian Moriarty, Co-Founder of Savant Bio. 'By linking Scipher's validated genomic insights with structured patient journeys, we are creating the foundation for the next generation of real-world evidence to enable faster studies, richer evidence, and more targeted therapies in RA.' Savant's platform uses large language models (LLMs), paired with domain-specific quality controls, to extract structured variables from free-text clinical documentation, such as physician notes and pathology reports. Key enriched dimensions include biologic sequencing, disease activity scores (e.g., CDAI, DAS28), steroid exposure, radiographic findings, and treatment durability. Each output undergoes rigorous review to ensure accuracy and consistency and can be linked to claims, labs, and prescribing data for longitudinal analysis. 'As the leader in autoimmune transcriptomic data, we've long believed that combining molecular precision with real-world outcomes is key to advancing drug development in autoimmune disease,' said Reg Seeto, CEO of Scipher Medicine. 'By integrating structured clinical data through Savant's platform, we aim to enhance the utility of the growing Scipher dataset for applications ranging from trial design to market access — and ultimately support more personalized, evidence-driven treatment strategies in autoimmune diseases.' Initial structuring is underway on a cohort of more than 6,000 PrismRA-tested patients, creating one of the most comprehensive genomically defined RA cohorts with structured EHR data. Additional expansion is planned. The dataset will support critical use cases, including: Validating real-world predictors of treatment response Mapping treatment sequencing and disease control Building precision cohorts for post-TNFi trials Supporting post-market studies and label expansion The enriched dataset will be made available through collaborative research initiatives, co-publications, and structured licensing partnerships. Interested organizations are encouraged to engage early to help shape use cases and gain preliminary access to insights. About Scipher Medicine Scipher Medicine is redefining drug development in autoimmune diseases through its precision diagnostics platform, real-world data, and network biology. The company's Prism ® platform uses genomic signatures to guide therapeutic selection and generate insights into treatment response. Scipher has built the largest genomic biobank in RA, which is coupled with access to EHR data from a network of over 3 million rheumatology patients. Learn more at About Savant Bio Savant is transforming how healthcare and life sciences organizations unlock the value trapped in unstructured medical data. Its data abstraction platform combines advanced large language models with domain-specific quality controls to convert free-text clinical records into structured, analysis-ready data — efficiently, accurately, and at scale. Backed by Roivant, Savant partners with leading institutions across healthcare, life sciences, and research to deliver sharper insights and better outcomes. Learn more at
